ArticleCureus2026
Metachronous Intracranial Germinoma Recurrence After Long-Term Remission: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial germinomas are rare central nervous system neoplasms. Their diagnosis relies on clinicoradiological correlation and tumor marker assessment. Radiotherapy alone often achieves complete remission; however, late recurrences in atypical locations have been reported, underscoring the importance of timely diagnosis, appropriate treatment, and long-term surveillance in patients with intracranial germinoma. We report the case of a 22-year-old man who presented with severe pulsatile headache, photophobia, phonophobia, vomiting, bilateral thigh weakness, and urinary incontinence. Computed tomography revealed a pineal tumor with obstructive hydrocephalus, prompting ventriculoperitoneal shunt placement. Tumor markers were elevated (serum beta human chorionic gonadotropin (β-hCG) 18.46 mIU/mL, cerebrospinal fluid (CSF) β-hCG 16.8 mIU/mL, serum alpha-fetoprotein (AFP) 2.71 ng/mL, and CSF AFP 0.2 ng/mL). Radiotherapy achieved complete remission; however, the patient subsequently developed radiation-induced hypopituitarism requiring lifelong hormone replacement therapy. Thirteen years after the initial diagnosis, surveillance imaging demonstrated periventricular and callosal enhancement associated with mildly elevated tumor markers. Biopsy revealed OCT4 and CD117 positivity, confirming a new germinoma interpreted as a metachronous neoplasm. This case highlights the value of comprehensive diagnostic evaluation and emphasizes the need for long-term, multidisciplinary follow-up due to the risk of late sequelae and atypical recurrences in patients with intracranial germinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.